psalexa
SearchBar Icon

Biosimilars Market By Product (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Recombinant Peptides), Technology (mAb, rDNA, Bioassays, Nuclear Magnetic Resonance, Electrophoresis), Indication (Oncology, Rheumatology, Blood-Related Disorders, Auto-Immune Diseases, Chronic Diseases, Infectious Diseases, Growth Hormone Deficiency), Route of Administration (Intravenous, Subcutaneous, Intranasal), Geographical Outlook – Trends Analysis and Growth Forecast to 2024

Biosimilars Market (2014-2024)
Published Report Code Available Format Pages
 April 2019  LS10997    187

Place an order

USD 5100
USD 6100
USD 9150